サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：自動細胞イメージングシステムの世界市場-2022-2029
市場調査レポート
商品コード
1166557

自動細胞イメージングシステムの世界市場-2022-2029

Global Automatic Cell Imaging System Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
自動細胞イメージングシステムの世界市場-2022-2029
出版日: 2022年11月30日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場の概要

自動細胞イメージングシステムの世界市場規模は、予測期間（2022-2029年）にCAGR9.1％で成長すると予測されています。

自動画像解析は、デジタル画像からデータを分離するためにソフトウェアを使用します。アルゴリズムは、画像内の特定の形状やパターンを識別し、定量的な情報をまとめ、細胞内の構造や機能に関する細胞イメージング研究に活用されます。これにより、ダイナミックな細胞プロセスをリアルタイムで可視化・定量化することができます。

市場力学

研究活動の活発化と様々な団体からの関連資金提供は、予測期間中の自動細胞イメージングシステムの世界市場の成長を後押しします。

研究イニシアティブや研究成果の増加は、世界市場における需要を促進します。

ライフサイエンスや生物医学の研究が進むにつれて、それらはより高度になり、科学の進歩に必要なデータスループットを維持するために自動化技術が必要とされています。生物学的プロセスの顕微鏡画像は、生物医学研究で使用される基本的なデータ取得・分析技術です。したがって、生物医学における研究イニシアティブと資金提供の増加は、世界の自動細胞イメージングシステム市場を後押ししています。例えば、独立したISREC財団は、ローザンヌとスイス西部の革新的ながん研究、特にがん患者の将来の治療にプラスの影響を与えることが保証されているトランスレーショナル腫瘍学の支援に焦点を当てました。さらに、2020年のNCIによる各種慢性疾患に対する研究費の推定予算は64億4040万米ドルであり、2024年度の専門判定予算案は99億8,800万米ドルです。同様に、2021年7月、すべてのがんに対する強力な免疫療法の発見と開発を通じてより多くの命を救うことを目的とする米国の非営利団体、がん研究所（CRI）は、2021年6月30日までの2021会計年度に2850万米ドル以上の研究助成金と研究員資格を授与したと報告しています。このように、バイオ医薬品のための研究イニシアティブと知見の増加が、予測期間中の自動細胞イメージングシステムの世界の成長を後押ししています。

自動細胞イメージングシステムの高いコストは、自動細胞イメージングシステムの世界市場の成長を阻害します。

しかし、自動細胞イメージングシステムの高コストが世界市場の成長を妨げると予想されます。例えば、Avantorによると、ImageXpress Pico Automated Cell Imaging Systemは、仕様に基づいて69,727.58ドルから81,637.99ドルの費用がかかります。

COVID-19の影響分析

COVID-19は、ポストCOVID以来、世界の自動細胞イメージングシステム市場にプラスの影響を与え、生物医学研究への投資が増加しました。例えば、非営利の医療・健康研究支援団体であるリサーチ・アメリカによると、米国（U.S.）の医療・健康研究開発（R&D）投資額は2020年に2451億米ドルに達し、2019年から11.1％増加しました。2020年の推定値は、官民の研究開発エコシステム全体における成長率の変化を示唆していますが、この変化はCOVID-19パンデミックに対する反応とその影響を主に反映していると思われます。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 政府・民間組織別投資
      • 技術革新と開発
    • 抑制要因
      • 自動細胞イメージングシステムの高コスト
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 タイプ別

  • コンピュータ制御タイプ
  • タッチパネル操作タイプ

第8章 技術別

  • 蛍光式
  • ルミネッセンス
  • 位相差
  • その他

第9章 アプリケーション別

  • ライブセル、インビボ・イメージング
  • スクリーニング
  • その他

第10章 エンドユーザー別

  • 病院・クリニック
  • 研究機関
  • 画像診断センター

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク

第13章 企業プロファイル

  • Thermo Fisher Scientific
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Axion BioSystems
  • Leica Microsystems
  • GE Healthcare Life Sciences
  • Olympus
  • BD
  • BioTek Instruments
  • PerkinElmer Inc.
  • HORIBA Medical
  • Oxford Instruments

第14章 DataM

目次
Product Code: DMMD1459

Market Overview

The global automatic cell imaging system market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 9.1% during the forecast period (2022-2029).

Automated image analysis employs software to isolate data from digital images. Algorithms identify specific shapes and patterns in the images and compile quantitative information that is then utilized in cell imaging studies of cellular structure and function in cells. It enables the visualization and quantitation of dynamic cellular processes in real-time.

Market Dynamics

The increasing research activities and related funding from various entities will boost the global automatic cell imaging system market growth during the forecast period.

The increased research initiatives and findings fuel its demand in the global market.

As life sciences and biomedicine studies advance, they become more sophisticated and require automated technology to maintain the data throughput necessary for scientific advancement. Microscopic imaging of biological processes is a fundamental data acquisition and analysis technique used in biomedical research. Therefore, the growing research initiatives and funding in biomedicine boost the global automatic cell imaging system market. For instance, the independent ISREC Foundation focused on supporting innovative cancer research in Lausanne and Western Switzerland, particularly translational oncology that is guaranteed to positively impact the future treatment of cancer patients. Moreover, in 2020 the estimated funding budget for research according to the NCI for various chronic diseases was $6,440.4 million, and the Professional Judgement Budget Proposal for the fiscal year 2024 is $9988 million. Similarly, in July 2021, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to saving more lives through the discovery and development of potent immunotherapies for all cancers, reported that it had awarded more than $28.5 million in research grants and fellowships during the 2021 fiscal year ending June 30, 2021. Thus, the increased research initiatives and findings for biomedicines are boosting the growth of the global automatic cell imaging system during the forecasted period.

The high cost of the automatic cell imaging system will hamper the global automatic cell imaging system market growth.

However, the high cost of the automatic cell imaging system is expected to hamper the global market growth. For instance, according to Avantor, the ImageXpress Pico Automated Cell Imaging System costs from $69,727.58 to $81,637.99 based on the specifications.

COVID-19 Impact Analysis

COVID-19 has positively impacted the global automatic cell imaging system market since post-COVID, and increased investments in biomedical research have been made. For instance, according to Research America, a non-profit medical and health research advocacy association, the United States (U.S.) medical and health research and development (R&D) investment reached $245.1 billion in 2020, an 11.1% increase from 2019. The 2020 estimates suggest changes in growth rates across the public-private sector R&D ecosystem, but it is likely these changes predominantly reflect the reaction to, and effect of, the COVID-19 pandemic.

Segment Analysis

Live cell and in vivo imaging are predicted to dominate the forecast period (2022-2029).

Live cell and in vivo imaging are estimated to hold most of the global automatic cell imaging system market throughout the forecast period (2022-2029) because of the new product introductions by various market payers. For instance, in Oct 2020, CytoSMART Technologies launched Multi Lux, a new automated live-cell imaging system developed for long-term experiments, comparison studies, and large laboratory teams. Similarly, in September 2021, PHC Corporation of North America and Screen Holdings Co., Ltd partnered to market the Screen Cell imager series of live cell imaging systems in North America. Additionally, in April 2022, CytoSMART technologies introduced the Omni FL, a new live-cell imaging analysis system containing red and green fluorescence channels, into its signature Omni product line for the first time. Furthermore, in June 2021, Leica Microsystems introduced its Leica Nano workflow, a brand new live-cell correlative light and electron microscopy (CLEM) workflow solution developed to improve experimental success rates, reproducibility and simplify light and electron microscopy (EM) integration. Thus, the increasing product introduction for live cell and in vivo imaging ensures its dominance over the global automatic cell imaging system market during the forecast period.

Geographical Analysis

The North America region holds the largest global automatic cell imaging system market share.

The North America automatic cell imaging system market is expected to grow at a high CAGR throughout the forecast period, owing to increasing initiatives by the government toward biomedical research. For instance, according to the American Association for the Advancement of Science, Congress created the Advanced Research Projects Agency for Health (ARPA-H), provided around $1 billion for startup investment, and has plans to provide $6.5 billion in funding. Furthermore, most of the key market players, such as Axion BioSystems, BD, BioTek Instruments, and Thermo Fisher Scientific, hold the majority of market share through various market strategies, ensuring the growth of the North America automatic cell imaging systems. For instance, in March 2022, Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, acquired the Netherlands-based CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis. Thus, the data above indicates that North America will hold most of the global automatic cell imaging systems market throughout the forecasted period (2022-2029).

Competitive Landscape

The automatic cell imaging system market is moderately competitive due to crucial local and global players involved in the research and innovation of new developments. Some of the key players include Axion BioSystems, Leica Microsystems, GE Healthcare Life Sciences, Olympus, BD, BioTek Instruments, PerkinElmer Inc., HORIBA Medical, Oxford Instruments, and Thermo Fisher Scientific. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 2020, CytoSMART Technologies introduced a new live-cell imaging system. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution to researchers carrying out immediate side-by-side comparisons between cell cultures.

ThermoFisher Scientific

Overview:

ThermoFisher is a U.S.-based company founded in 1956. It is the world leader in serving science with annual revenue of approx. $40 billion has industry-leading brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

Product Portfolio:

The product portfolio of ThermoFisher for Automatic Cell Imaging System has EVOS Cell Imaging Systems: EVOS imaging systems contain high-resolution cameras, bright and digitally controlled LED light sources, and automatic software to help capture stunning, publication-quality images in just a few clicks. These fully automated, multichannel fluorescence or brightfield microscopes feature advanced imaging tools to handle time-lapse movies, multiwell plate scanning, image stitching and tiling, and cell counting.

The global automatic cell imaging system market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Investments By Government and Private Organizations
      • 4.1.1.2. Innovations and Developments
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of automatic cell imaging system
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Computer Controlled Type
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Touch Screen Operate Type

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Fluorescence
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Luminescence
  • 8.4. Phase Contrast
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Live Cell and In Vivo Imaging
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Screening
  • 9.4. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals And Clinics
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Research Centers
  • 10.4. Diagnostic Imaging Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Thermo Fisher Scientific
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Axion BioSystems
  • 13.3. Leica Microsystems
  • 13.4. GE Healthcare Life Sciences
  • 13.5. Olympus
  • 13.6. BD
  • 13.7. BioTek Instruments
  • 13.8. PerkinElmer Inc.
  • 13.9. HORIBA Medical
  • 13.10. Oxford Instruments

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us